AI assistant
Sending…
ABEONA THERAPEUTICS INC. — Director's Dealing 2021
Jun 3, 2021
33413_dirs_2021-06-03_14fd3022-59db-4d65-8b3f-5871b869e465.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ABEONA THERAPEUTICS INC. (ABEO)
CIK: 0000318306
Period of Report: 2021-06-01
Reporting Person: Seshadri Vishwas (SVP, Head of Res./Clin. Dev.)
More from ABEONA THERAPEUTICS INC.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Proxy Solicitation & Information Statement
2026
May 4
Major Shareholding Notification
2026
Apr 28
Annual Report
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27